Plasma-Activated Ringer’s Lactate Solution Fabricated Through a Microfluidics Plasma System: A Dual Mechanism Approach for Targeting Lung Cancer Cells

Journal of Applied Electrochemistry · Springer Nature · 2026-10-27 · DOI: 10.1007/s13206-026-00283-w

Аннотация

Plasma-activated solutions offer a promising approach for cancer treatment, but conventional open systems provide limited control over reactive species generation. This study developed a closed, segmented-flow microfluidics plasma system to generate plasma-activated Ringer’s lactate solution (PAL) and evaluated its chemical properties and anticancer activity in A549 lung cancer cells. Ringer’s lactate solution and helium were supplied at 100 µL/min and 5.0 sccm, respectively, and treated at 5.0 to 7.0 kV. PAL was characterized, while cytotoxicity and cell-death mechanisms were assessed using viability assays, flow cytometry, inhibitors, and Western blot. Increasing voltage decreased the pH and increased H 2 O 2 and chlorine-derived oxidants. At 6.0 kV, 30% PAL contained 207 µM H 2 O 2 and reduced A549 viability to approximately 22%, while the tested non-A549 cell models retained over 90% viability. Catalase-rescue experiments supported an essential role for H 2 O 2 in PAL-induced cytotoxicity, whereas component-resolved plasma-treated solutions implicated chlorine-derived oxidants as additional contributors. The closed microfluidic configuration enabled voltage-dependent modulation of the ROS and RClS profiles in PAL, resulting in selective cytotoxicity toward A549 lung cancer cells. Therefore, the results demonstrated that PAL generated by microfluidics plasma system is a tunable anticancer platform that selectively induces apoptosis and ferroptosis in A549 lung cancer cells. Graphical Abstract

Читать у издателя →

Похожие статьи